Background: Antimicrobial lock therapy has been widely utilized internationally for the prevention and management of intravascular catheter-related bloodstream infections. One of the agents commonly utilized for lock therapy is ethanol. However, a systematic review of adverse events associated with ethanol locks has not been published. Results: In vitro studies of the mechanical properties of catheters after ethanol immersion have revealed changes predominantly in polyurethane catheters and to a lesser extent in silicone and Carbothane catheters. An elution of polymers from polyurethane and Carbothane catheters has been observed at the ethanol concentrations used in ethanol lock therapy. Ethanol above a concentration of 28% leads to plasma protein precipitation. Ethanol locks were associated with catheter occlusion in 11 studies and independently increased the risk of thrombosis compared with heparin lock in a randomized trial. Six studies noted abnormalities in catheter integrity, including one case leading to catheter embolization. Of note, five of these studies involved silicone catheters. Ethanol lock use was associated with systemic side effects in 10 studies and possible side effects in one additional study. Four studies noted liver function test abnormalities, predominantly transaminase elevation, related to ethanol lock use. However, a prospective study did not find any difference in the risk of doubling the transaminase level above the normal range during use of ethanol locks compared with not using an ethanol lock.
Introduction
Intravascular catheters have been flushed or locked with ethanol for various purposes over the last 25 years. Ethanol has been utilized to dissolve intraluminal obstruction caused by waxy lipid deposits associated with the administration of total parenteral nutrition. 1 -4 More recently, ethanol lock solutions have been used predominantly for the prevention and occasionally for the management of catheter-related infection, as noted in recent reviews 5 -8 and case series. 9 Despite the enthusiasm for the use of ethanol lock solutions in various patient populations, as evidenced by the numerous publications cited in these reviews, few prospective, randomized trials exist that have thoroughly assessed their efficacy and safety. As such, most clinicians are unaware of the safety profile of ethanol lock solutions and the effect of ethanol on proteins in plasma or erythrocytes in whole blood, on biofilms formed by various microbial pathogens, on catheter integrity and on the elution of catheter material after exposure to ethanol.
Ethanol modifies the deformability and fluidity of erythrocytes in a dose-dependent fashion, which can increase risk of haemolysis. 10, 11 Ethanol is also known to precipitate plasma proteins in a dose-dependent fashion. 12, 13 Some in vitro studies suggest that ethanol can eradiate various bacteria within biofilms, with variable efficacy, depending on the ethanol concentration and the exposure time. 14, 15 However, other investigators have found that increasing concentrations of ethanol from 20% to 100%, particularly ethanol concentrations of 40% or more, correlate with increasing biofilm formation of Staphylococcus aureus. 16 Additionally, exposure of S. aureus to ethanol increases the expression of antibiotic resistance factors, as seen with the up-regulation of antibiotic efflux pumps. 16 Low concentrations of ethanol have also been shown to enhance the biofilm formation of Staphylococcus epidermidis. 17 Ethanol lock solutions have the potential for causing disulfiram reactions in patients receiving metronidazole. 18 Ethanol may also interact with other medications instilled through the catheter after the use of ethanol lock solutions. 7 Finally, ethanol has no anticoagulant properties and may induce coagulation by protein denaturation. 19 The contents of catheter lock solutions leak into the bloodstream due to the parabolic flow distribution inside the catheter during injection and to a greater extent because of gravityinduced discharge from the distal end of the catheter because of differences in fluid density between the catheter lock solution and the blood. 20 Leakage of lock solutions into the systemic circulation due to gravity varies depending on body position. 21, 22 As the lock solution is discharged from the distal end of the catheter, blood enters the catheter lumen, allowing plasma proteins to interact with the ethanol lock solution. 20 Thus, the ethanol concentration within the lumen may vary, with a gradient of higher to lower concentration from the proximal to the distal end of the catheter, as has been demonstrated with antibiotic lock solutions. 21 We set out to assess in vitro studies and clinical studies of ethanol lock solutions with the specific intent of assessing and shedding light on the risk of systemic side effects and the impact on the catheter material and intraluminal contents.
Methods
PubMed was searched to collect articles available online published May 2003 through March 2014, as well as relevant articles from bibliographies to determine whether patients receiving ethanol catheter lock solutions had untoward effects potentially caused by ethanol lock solutions, and the available peer-reviewed literature regarding the effect of ethanol on intravascular catheter integrity. Search terms included ethanol lock technique, ethanol lock therapy, adverse effects of ethanol lock therapy, intravascular catheter occlusion/thrombosis, catheter-related infection and ethanol, catheter disruption and ethanol, leakage repair and ethanol, interaction of ethanol with other substances, systemic effects of alcohol lock, catheter-related infection and ethanol, and bloodstream infection, prevention and treatment and ethanol. Only peer-reviewed articles were assessed. Clinical studies were included in this analysis if it could be determined that the side effects of ethanol lock use had been assessed, and if so whether any patients had had an adverse reaction. In vitro studies were included if the methodology for assessing the interactions between the ethanol and the catheters had been noted.
Results
Using PubMed, the above-noted search terms identified 402 articles. Eight in vitro studies and 20 clinical studies met our inclusion criteria. The in vitro studies on the impact of ethanol lock solutions on catheter integrity are summarized in Table S1 (available as Supplementary data at JAC Online). Studies utilizing scanning electron microscopy to assess the catheter surface after ethanol immersion have noted micro-cracks or degeneration of the internal wall of polyurethane catheters, 23, 24 but the concentration of ethanol used in some of these studies was greater than the concentration used in ethanol lock solutions. Time-dependent abnormalities of the inner surface of the catheter have been noted for Carbothane catheters, made of polycarbonate-based aliphatic and aromatic polyurethanes, 25 but no such changes have been noted with silicone catheters. 26 Some studies have assessed the mechanical properties of catheters after ethanol immersion. One such study found that polyurethane, but not silicone, catheters showed an increased wall thickness after ethanol exposure, with a reduced modulus of elasticity for polyurethane and silicone catheters, but no significant change in the force at break, maximum stress at break or maximum segment elongation and strain immediately prior to break with either catheter type. 27 The immersion of Carbothane catheters in ethanol led to a significantly reduced force at break, a shorter elongation at break and an increased catheter weight but no significant change in the modulus of elasticity. 28 A number of studies have assessed the elution of various molecules from the catheters during immersion in ethanol. An elution of condensed polymers of 1,4-butanediol from polyurethane catheters has been noted. 24 An elution of polydimethylsiloxanes from silicone catheters was noted after immersion in 95%, but not 60%, ethanol. 26 A time-dependent elution of predominantly the polycarbonate diol component has been observed with Carbothane catheters. 25 In sum, scanning electron microscopy studies have noted changes in Carbothane catheters at the ethanol concentrations used in ethanol lock solutions, but not in silicone catheters after exposure to ethanol. Changes in the mechanical properties of polyurethane and Carbothane catheters have been observed after ethanol exposure, but less so with silicone catheters. An elution of polymers has been observed from polyurethane and Carbothane catheters but not from silicone catheters at the ethanol concentrations commonly used in ethanol locks. Ethanol solutions above a concentration of 28% as a lock solution caused protein precipitation in plasma samples during the in vitro simulation of various catheter insertion positions. 20 Of note, the precipitate cannot be redissolved by dilution with urokinase or alteplase.
Studies revealing a systemic effect of ethanol lock use or an adverse impact on lumen patency or catheter integrity are summarized in Table 1 . In 10 studies, 29,31 -35,42 -44,47 patients demonstrated systemic symptoms likely to be related to ethanol lock use, with possibly the same noted in an additional study. 36 The ethanol lock was flushed in five of these studies 29, 31, 35, 43, 47 and aspirated in five studies, 32, 33, 36, 42, 44 and no procedure was specified in one study. 34 In the one prospective, randomized trial, the incidence of such symptoms was significantly greater in the ethanol lock group. 35 In three studies 29, 36, 38 and possibly an additional one, 39 transaminase levels above baseline and/or greater than those seen in individuals not receiving ethanol locks was observed. Three of these four studies 29, 38, 39 involved flushing of the ethanol lock. One prospective study assessed for a doubling in transaminase levels above the normal range and found no difference in patients receiving an ethanol lock compared with those receiving a lock solution not containing ethanol. 47 Eleven studies 19,30,34,36 -38,40 -42,45,46 noted problems with catheter occlusion. In seven of these studies the lock was aspirated, 19, 30, 36, 37, 41, 42, 46 in three it was flushed 38, 40, 45 and in one study no procedure was specified. 34 In one prospective study this was significantly more common when an ethanol lock was used as opposed to a lock solution not containing ethanol. 41 In one study, an ethanol lock independently increased the risk of thrombosis compared with a heparin lock (OR 10.5, 95% CI 1.2-91.3). 46 Six studies 34 -37,42,46 noted a breach in catheter integrity with ethanol lock use. The ethanol lock was aspirated, flushed or not specified in four studies, 36, 37, 42, 46 one study 35 and one study, 34 respectively. Of note, five of these Systematic review 34 -37,46 specified the catheter material and in each case a silicone catheter was used. In one study increasing the catheter size from 2.7 Fr to 9.6 Fr independently reduced the risk of line repair (OR 0.13, 95% CI 0.03-0.58). 46 
Discussion
Although ethanol lock solutions demonstrate efficacy when used in a prophylactic fashion and for the management of catheterrelated bloodstream infection, 5 -9 untoward effects have been noted by several investigators. The incidence of systemic side effects, breaches in the integrity of the catheter or catheter obstruction due to ethanol lock use may be underappreciated since most articles in the published literature are retrospective and these details may have been missed by clinicians at the time or during retrospective chart review, or may have been observed and otherwise explained or not documented. In the four prospective, randomized trials 32, 35, 42, 47 severe adverse events occurred only in the ethanol lock group, 35, 47 rupture or splitting of the catheter was seen only in the ethanol group 35, 42 and a significant difference in early discontinuation of the randomized lock use occurred only in the ethanol group. 35, 47 In the one prospective trial alternating ethanol and standard lock use, 41 there was a significantly greater incidence of both catheter dysfunction and complete catheter occlusion when an ethanol lock was used. What is clear from the published literature is that systemic symptoms may be observed with ethanol locks of various concentrations whether or not they have been aspirated after the dwell time or flushed, the former due to inexorable seepage from the distal aspect of the catheter. In some studies, such seepage has also been associated with elevation of transaminase levels. An increased incidence of catheter occlusion has been noted in several studies correlating with in vitro studies of plasma precipitation in catheter lumens from blood that has filled the intraluminal void after seepage of the lock solution. This may also reflect the fact that ethanol is not an anticoagulant. Finally, breaches in catheter integrity have been noted in several clinical studies, in some cases with embolization of the catheter 36 despite the minimal changes in the mechanical properties of silicone catheters noted in in vitro studies.
Based on the available literature, we have the following recommendations regarding ethanol lock solution:
(1) All manufacturers should rigorously assess the effect of various concentrations of ethanol lock solutions on catheter integrity and polymer elution to guide the use of such solutions in the clinical setting. Ethanol locks should only be used in catheters approved for such use by manufacturers. (2) Consensus recommendations should be made regarding the optimal ethanol concentration, the minimal dwell time for efficacy and catheter compatibility, and the recommendations should note whether additional ingredients are necessary to minimize intraluminal obstruction and inhibition rather than the stimulation of biofilm formation. At the present time an ethanol lock should be used with great caution and only in catheters that are manufacturer-approved for use with ethanol locks, and the lock solution should be aspirated rather than flushed after the dwell time is complete, as well as with close observation for symptoms and monitoring for laboratory evidence of alcohol toxicity. Adding an additional
Pérez-Granda et al. increasing ethanol concentration and duration of exposure 25, 26 and plasma protein precipitation after exposure to ethanol is also concentration dependent. As such, if an ethanol lock is used, the shortest dwell time and lowest concentration needed to eradicate microbes in biofilm may reduce the risk of seepage and systemic toxicity, plasma precipitation and altered catheter integrity.
